Full-Time

Associate Director

Medical Writing

Confirmed live in the last 24 hours

Kymera Therapeutics

Kymera Therapeutics

201-500 employees

Develops targeted protein degradation therapies

Biotechnology
Healthcare

Senior

Belmont, MA, USA

This position offers a hybrid work model.

Category
Technical Writing
Content & Writing
Medical, Clinical & Veterinary
Required Skills
Google Cloud Platform
PowerPoint/Keynote/Slides
Requirements
  • BS/BA in the life sciences or related field and at least 5 years of clinical regulatory writing in biotech/biopharma.
  • Demonstrated successful experience as a lead writer for clinical protocols, IBs, CSRs, Module 2 summaries and other clinical and regulatory documents.
  • Strong knowledge of FDA and ICH guidelines, GCP, and applicable US and international regulatory processes related to document preparation. Experience as contributing author for regulatory submissions is desired.
  • Experience with development and implementation of templates, processes, and procedures supporting the MW function.
  • Proficiency in understanding, critically analyzing, and interpreting data and summarizing complex results in a clear, concise, and scientifically accurate manner.
  • Experience with Microsoft Office Suite (Word, Excel, PowerPoint, and Project); Word toolbars/templates (StartingPoint, TransCelerate); SharePoint; Adobe Acrobat (Standard, Pro); EDMS (Veeva RIM); smartsheet; and PleaseReview.
  • Experience with RightFind and reference citation software (EndNote, Reference Manager).
  • Well-developed interpersonal skills, with experience interacting with and influencing people, and building strong positive relationships.
  • Ability to thrive in a fast-paced small company environment with an ability to balance competing priorities.
  • Strong project management skills.
  • Excellent attention to detail and strong written and verbal communication skills.
Responsibilities
  • Lead and/or manage the development of clinical and regulatory documents (e.g., protocols and amendments, Investigator’s Brochures, CSRs, Briefing Packages) with specific attention to document organization and quality, and adherence to Kymera standards and style.
  • Provide strategic guidance to program/project teams for document timeline development and resource planning.
  • Manage external medical writing vendors including facilitating onboarding to Kymera standards and systems and acting as the conduit from internal to external teams.
  • Facilitate effective roundtable discussions and record and communicate team-aligned decisions.
  • Manage document development and review process, including KOMs, team roundtables, and governance reviews.
  • Lead or participate in process-improvement initiatives, SOP development and updates.

Kymera Therapeutics develops treatments by targeting and breaking down specific proteins that contribute to diseases, particularly cancer and immune disorders. Their main technology, the Pegasus Platform, enables them to identify these harmful proteins and create drug candidates aimed at effectively treating various conditions. Unlike many competitors, Kymera focuses on targeted protein degradation, which can lead to more precise therapies. The company's goal is to create next-generation medicines that address unmet medical needs, supported by partnerships with organizations like Sanofi to enhance their research and development efforts.

Company Stage

IPO

Total Funding

$191.6M

Headquarters

Cambridge, Massachusetts

Founded

2016

Growth & Insights
Headcount

6 month growth

-1%

1 year growth

0%

2 year growth

15%
Simplify Jobs

Simplify's Take

What believers are saying

  • Kymera's $225M and $275M offerings indicate strong market confidence in biotech innovations.
  • The unveiling of KT-294 highlights a promising market for oral therapies in immune disorders.
  • HSBC's investment in Kymera suggests potential for further institutional investments.

What critics are saying

  • Increased competition from Arvinas and Nurix could impact Kymera's market share.
  • Regulatory scrutiny may delay clinical trials and affect drug approval timelines.
  • Reliance on partnerships like Sanofi poses risks if collaborations don't yield expected results.

What makes Kymera Therapeutics unique

  • Kymera's Pegasus Platform uniquely targets disease-causing proteins for degradation.
  • The company focuses on innovative treatments for cancer and immune disorders.
  • Kymera's strategic partnership with Sanofi enhances its position in the pharmaceutical ecosystem.

Help us improve and share your feedback! Did you find this helpful?